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Summary Study objectives: The purpose of this study was to compare comfort
parameters and pressure profiles of the AutoSetTM (Resmed) and the SOMNOsmartTM
(Weinmann), two auto-adjustable positive airway pressure (APAP) devices. Setting:
The sleep disorders center of a university hospital. Design: A single-blind randomized
trial protocol was applied. A split night procedure allowed each patient to be treated
in a crossover fashion with both APAP devices during one overnight study. Patients and
methods: Fifty consecutive obstructive sleep apnea (OSA) patients were recruited.
Each patient filled out an evaluation form for both devices after the study night.
Visual analogue scales were used to score four comfort measures. Three CPAP
outcomes generated by the devices (P50; P95 and Pmax) were assessed, compared with
each other and correlated with the individually predicted CPAP (Ppred). Results: Forty-
five males and 5 females, mean age 53.0 years, body mass index 31.0, were included.
The mean apnea-hypopnea index was 58.7, the mean arousal index was 54.3. Mean
CPAP-compliance before the titration study was 4.9 h per night. Comparison of the
two devices regarding the effect on the subjective sleep quality parameters showed
no differences. The AutoSetTM pressure outcomes correlated significantly better with
Ppred in comparison with the SOMNOsmart
TM. The P50 and P95 but not the Pmax values
were significantly lower in the SOMNOsmartt as compared with the AutoSetTM (P50:
5.171.3 vs 7.171.9mbar, Po0:0001; P95: 7.873.0 vs 9.671.9mbar, Po0:0005; Pmax:
10.073.4 vs 10.871.8mbar, NS). Conclusion: While the subjective tolerance of the
two APAP machines was comparable, these devices were characterized by different
pressure profiles. The pressure parameters of the AutoSetTM correlated better with
Ppred than those of the SOMNOsmart
TM.
r 2003 Elsevier Science Ltd. All rights reserved.
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Introduction
Ever since the landmark publication by Sullivan
et al. two decades ago,1 nasal continuous positive
airway pressure (CPAP) has been the mainstay for
treatment of patients suffering from moderate to
severe obstructive sleep apnea (OSA). In recent
years, several new devices have been developed
that are designed to deliver auto-adjustable posi-
tive airway pressure (APAP) meeting the patient’s
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instant pressure needs.2 These devices have the
theoretical advantage of stabilizing the upper
airway during changing physiological conditions,
which require different CPAP levels.3
Although different algorithms for driving APAP
are used by different manufacturers, APAP
devices in general have been shown to be
useful in the assessment of CPAP requirements
both in the sleep laboratory and at home.4
We elected to study two devices whose operation
is based on pro-active pressure augmentation
following the detection of incipient upper
airway obstruction. The operational characteristics
of the AutoSetTM (ResMed, Sydney, Australia)
feature detection of flow limitation (FL) of
inspired air and subsequent pressure adaptation.5
The SOMNOsmartTM (Weinmann, Hamburg, Ger-
many) measures upper airway impedance using
the forced oscillation technique (FOT). Pressure
adjustments are based on changes in the impe-
dance values.6
The aim of this study was to compare both
devices in terms of subjective tolerance and
pressure parameters. From a theoretical point of
view, one should obtain comparable figures regard-
ing tolerance and pressure output, if both devices
prove to perform equally well. In addition, one
would expect to find a correlation between the
pressure generated by these devices and individu-
ally predicted pressure (Ppred), which has been
shown to be significantly related to manually
titrated CPAP.7
Methods
Subjects
The target population were OSA patients who
demonstrated an apnea-hypopnea-index (AHI)
>20/h plus an arousal-index >30/h (i.e. Belgian
criteria for reimbursement of nasal CPAP). All
consecutive patients who underwent polysomno-
graphy in our sleep laboratory from January till
September 2001 and who fulfilled these inclusion
criteria, were asked to participate in the study.
Exclusion criteria included a history of prior UPPP,
signs of severe nasal obstruction, excessive sleep
fragmentation due to nonrespiratory causes and
COPD (i.e. FEV1/FVC o65%). None of the selected
individuals refused to take part in the trial and
none met the exclusion criteria. The participants
gave written informed consent to the trial, which
was approved by the Ethical Review Board of our
institution.
CPAP habituation
Before carrying out the APAP procedure, patients
were tried out on home CPAP treatment. The CPAP
was empirically set at a predicted pressure value
(Ppred), which is derived from a formula published
by Miljeteig et al.8 This formula takes into account
the AHI, neck circumference (NC) and the body
mass index (BMI) ½Ppred ¼ 0:13 BMIþ 0:16 NCþ
0:04 AHI 5:12: Patients may habituate this way
to CPAP for some months before being restudied in
the sleep laboratory. They were, however, in-
structed to contact our service for further help
and CPAP adjustment whenever necessary, e.g.
when snoring or sleep disruption persisted at Ppred:
Trial protocol
After the habituation period, the patients were
hospitalized for one night to carry out a crossover
study in which the APAP devices were used during
half of the night in randomized order. The patients
had no previous experience with these appliances
and were unaware of the operational features. By
covering the devices in identical boxes, true
blinding to the intervention was assured. They
were instructed to breathe normally and not to
talk, cough or swallow during a settling period of
5min prior to starting the actual titration proce-
dure. After the participants had been using the first
APAP device for 3.5 h, the mask was disconnected
and switched to the hose of the next machine,
which was then used for another 3.5 h. The 5min
adaptation procedure as described above was
repeated.
The pressure data of the APAP devices were
obtained for further analysis. During operation,
these devices continuously log the pressure curve
and store the data into electronic memory. After
downloading the memory to a computer, the
dedicated software computes statistical indices,
including the median (P50), 95th percentile (P95)
and maximum pressure (Pmax) over the timespan
during which the machine was being used. These
indices are important because they summarize the
overall level of pressure requirements and fluctua-
tions around this level in individual patients.
The patients were requested to fill out a
questionnaire upon awakening in the morning.
Visual analogues scales ranging between 0 (best
score) and 10 (worst score) were used to answer
four questions pertaining to the first and last used
APAP machine separately: (a) Did the pressure
changes disturb my falling asleep? (b) Did the
pressure changes cause awakenings? (c) How did
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the APAP device affect my sleep quality? (d) Did the
noise of the device disturb my sleep? In addition,
the patients were asked to indicate their pre-
ference for one of the APAP machines as if they
would have to choose between them for continued
use at home.
Technical settings of the APAP devices
The AutoSetTM was programmed to a pressure range
between 4 and 14 cm H2O. The AutoSet
TM long air
tube was used. The following settings were applied:
‘‘standard’’ mask setting; mask fitting feature not
used; ramp: off; settling time: 5min; humidifier:
off; leak alert: off; smart start: on.
The SOMNOsmartTM was also set to a pressure
range between 4 and 14 cm H2O. The default
settings of the device were kept. A standard
Weinmann hose was used.
Each patient wore the same type of mask
(Respironics Profile LightTM) and air exhaust (Re-
spironics Whisper SwivelTM). While ResMed does not
recommend the use of non-ResMed masks with the
AutoSetTM, we checked the compatibility with
Respironics Profile LightTM mask and found no
inconsistencies in pressure delivery.
The concordance between the pressure indicated
on the APAP devices and the recorded pressure
levels was verified and found to correspond within
limits of 70.5mbar.
Statistical analyses
In keeping with the crossover design, the Wilcoxon
matched pair test was applied for evaluating
differences between identical groups. The concor-
dance between groups was evaluated using Spear-
man’s correlation. P-values less than 0.05 were
considered to indicate statistical significance.
Results
Forty-five males and 5 females were included in the
study. The age (mean7SD) was 53.0710.6 years,
the body mass index was 31.075.3 kg/m2, the neck
circumference was 43.573.9 cm. The apnea-hy-
popnea-index was 58.7734.9, the arousal-index
was 54.3724.2. The number of days of CPAP
habituation prior to the study was 97.7782.4.
The CPAP-compliance during that period was
4.972.4 h per night. Ppred was 8.272.0mbar.
While the results of the subjective evaluation
scores varied between very good (0) and very bad
(10) for all parameters under consideration, the
median values were between 1 and 2, and the
interquartile ranges were o5, indicating that the
overall comfort of both devices was satisfactory to
most patients. No significant differences were
found between the devices in any of the subjective
parameters. The patients’ first choice corre-
sponded with the AutoSetTM in 25 cases, with
SOMNOsmartTM in 20 and remained indifferent in 5.
The SOMNOsmartTM produced significantly lower
values (mean7SD; 95% confidence intervals) re-
garding P50 (5.171.3; 4.8–5.5mbar) and P95
(7.873.0; 6.9–8.6mbar) as compared with the
AutoSetTM (7.171.9; 6.6–7.7 and 9.671.9;
9.110.1mbar, respectively) (Po0:0001 and
Po0:0005; respectively). Pmax values, on the other
hand, were not significantly different (SOMNOs-
martTM: 10.073.4; 9.1–11.0mbar; AutoSetTM:
10.871.8; 10.211.3mbar; NS).
Figure 1 illustrates the distribution characteris-
tics of the pressure parameters in comparison with
the predicted pressure. Ppred was mostly found in
the 6.5–7.5mbar range. While Ppred and the P50 of
the AutoSetTM matched a normal distribution
pattern, the P50 of the SOMNOsmart
TM remained
close to the lowest preset limit (4.5mbar) in 36
patients. P95 was most prevalent at about 4.5–
5.5mbar in the SOMNOsmartTM and around 10.0–
12.0mbar in the AutoSetTM. The SOMNOsmartTM
was also remarkable for a large number of Pmax
values equal to 14.0mbar. The different pressure
outcomes of the AutoSetTM correlated better with
Ppred than those of the SOMNOsmartt (Fig 2).
Discussion
Although the application of APAP devices has been
the subject of recent investigation in sleep dis-
ordered breathing, this isFto our knowledgeFthe
first study to compare two such devices in a clinical
setting. It was shown that APAP machines that are
driven on different measurements of upper airway
obstruction and that operate on different pressure-
adjusting algorithms yield different pressure out-
comes. Nonetheless, the devices under study,
namely the AutoSetTM and the SOMNOsmartTM,
received for the most part satisfactory comfort
scores by the patients and no differences in
subjective tolerance could be demonstrated.
While P50 and P95 values were distinctly lower in
the SOMNOsmartTM as compared with Ppred and the
AutoSetTM, more patients were exposed to max-
imum pressure levels when using the SOMNOs-
martTM. This finding would indicate that the
pressure generated by the SOMNOsmartTM tends
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to vary more between extreme levels and that the
pressure output of the AutoSetTM tends to cluster
more around intermediate values. Although this
observation could be explained by different pa-
tient-related conditions that determine the status
of upper airway obstruction, such as wakefulness,
sleep state and body position, the potential effect
of such confounders should have been limited by
the randomized and crossover design of the study.
Indeed, we believe that the technical character-
istics of the devices account for most of the
observed differences.
An important dissimilarity between the two APAP
devices, is the reaction times (DP=Dt) that deter-
mine the rate at which the pressure adjustments
are to be made. The slope of adaptation is steeper
in response to certain respiratory events in the
SOMNOsmartTM. In response to elevated impe-
dance, the pressure is increased with 0.2mbar/s
or 12mbar/min (adjustable to 0.4 or 0.6mbar/s).
When no elevated impedance is detected, the
pressure is lowered within a time channel between
16 and 120 s at a 0.05mbar/s rate. After 120 s the
device decreases the pressure at a 0.1mbar/s rate.
Pressure adaptation is much slower in the Auto-
SetTM. Significant FL will induce CPAP increments of
0.2mbar/tidal volume (72mbar/min), whereas
the CPAP will remain unchanged with mild FL.
Unobstructed breathing, which is characterized by
absence of FL, will cause an exponential decline in
CPAP, using a time constant of 20min.9
The present study has several limitations. Of
most importance is the fact that the efficacy of the
devices was not assessed in terms of their cap-
ability to reduce sleep disordered breathing
events. Since sleep was not recorded and AHI not
computed, we cannot conclude from this study
which device is better than the other. On the other
hand, the large number of subjects included, the
blinding and the randomized trial design add
credits to the strength of the study. We elected
to use Ppred as reference outcome, since it was
shown that Ppred corresponds closely to the manu-
ally titrated effective CPAP in 63% of patients and
that the two measures are within 72mbar in
83% of patients.7 Accordingly, we found that all
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Figure 1 Frequency distribution of predicted pressure, SOMNOsmartTM and AutoSetTM pressure profiles
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pressure variables of the AutoSetTM correlated
significantly with Ppred: Only the P50 of the SOM-
NOsmartTM showed a slightly significant concor-
dance with Ppred; the other pressure variables were
not significantly correlated. Though formal proof is
lacking, this observation suggests that the Auto-
setTM is more suitable for determining a prescrip-
tion pressure for fixed CPAP treatment. Since the
AutosetTM is closer related to Ppred; one may assume
that it might perform better in trials aimed at
determining average effective CPAP values.
In conclusion, we have shown that the pressure
profiles of the SOMNOsmartTM and AutosetTM are
significantly different. Though we did not provide
evidence that one device is superior to the other,
our observation may at least cast some doubt on
the contention that all APAP machines are equally
effective in controlling sleep disordered breathing.
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Figure 2 Correlation of SOMNOsmartTM and AutoSetTM pressure profiles, as compared with predicted pressure. All
pressure values are mbar. r=Spearman’s r:
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If so, one would expect a better concordance of the
different pressure output variables. From the
present study it is clear that the pressure outcomes
of one device cannot be extrapolated to another. To
address the question of efficacy, one has to await
the results of trials that evaluate the effects of
APAP machines on sleep and respiratory variables in
a comparative protocol.
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